CNX Therapeutics Limited (“CNX Therapeutics”), a leading European specialty pharmaceutical company, has today announced an exclusive partnership with Adalvo to commercialise a prolonged release ...

Craig A Clifford, DVM, MS, DACVIM (Oncology) talks about the most common bladder tumor in dogs, misdiagnosis, and the Cadet ...

Lightweight and able to expand up to 31 inches in length, the mobility aid acts as an extendable arm to help pick up small ...

While 96% of Australian mothers intend to breastfeed, 34% of babies have been given formula in their first month, and ...